Alternative approach to treating malignant glaucoma after trabeculectomy with unplanned zonulectomy.
OBJECTIVE
To report the role of Healon5 injection combined with medications in patient with malignant glaucoma after trabeculectomy with unplanned zonulectomy.


METHODS
Two days after trabeculectomy with unplanned zonulectomy for neovascular glaucoma in an eye with diabetic retinopathy, a patient developed malignant glaucoma due to the ciliovitreal block caused by the vitreous herniation through the peripheral iridectomy to the limbal incision with flat bleb and anterior chamber, and the intraocular pressure was elevated to 33 mmHg. The medications for the management of malignant glaucoma failed to relieve the malignant mechanism, and Healon5, a viscoadaptive, viscoelastic, and ophthalmic viscosurgical device, was injected through a paracentesis until the anterior chamber became deep enough to block the vitreous herniation to the limbal incision.


RESULTS
After Healon5 injection, the intraocular pressure was reduced enough that the bleb was re-formed, and the anterior chamber remained deep, even without medication.


CONCLUSIONS
In patients presenting with malignant glaucoma after trabeculectomy with unplanned zonulectomy, Healon5 injection, combined with medications, may be a safe and effective approach before performing vitrectomy.
Ozeki
Naoki
N
Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan.
Yuki
Kenya
K
Kimura
Itaru
I
Arch Ophthalmol. 1986 Oct;104(10):1464-6
3767675
J Cataract Refract Surg. 2002 Apr;28(4):712-4
11955917
J Cataract Refract Surg. 1997 Mar;23(2):284-8
9113583
Ophthalmic Surg Lasers. 1997 Jan;28(1):30-6
9031302
J Cataract Refract Surg. 2001 Feb;27(2):320-6
11226801
Arch Ophthalmol. 1989 Nov;107(11):1609-11
2818280